Maravai LifeSciences Holdings, Inc. MRVI Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s long-term debt?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported long-term debt of $235.57M in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s long-term debt changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s long-term debt decreased by 18.6% year-over-year, from $289.5M to $235.57M.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s long-term debt?
- Over 5 years (2020 to 2025), Maravai LifeSciences Holdings, Inc.'s long-term debt has grown at a -11.5% compound annual growth rate (CAGR), from $528.61M to $286.33M.
- What does long-term debt mean?
- Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.